BBIO
BridgeBio Pharma, Inc. - Common Stock (BBIO)
$78
About BridgeBio Pharma, Inc. - Common Stock (BBIO)
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Details
Daily high
$39.82
Daily low
$38.57
Price at open
$38.96
52 Week High
$40.40
52 Week Low
$21.62
Market cap
7.6B
Dividend yield
0.00%
Volume
2.6M
Avg. volume
2.4M
P/E ratio
-11.27
BridgeBio Pharma, Inc. - Common Stock News
Details
Daily high
$39.82
Daily low
$38.57
Price at open
$38.96
52 Week High
$40.40
52 Week Low
$21.62
Market cap
7.6B
Dividend yield
0.00%
Volume
2.6M
Avg. volume
2.4M
P/E ratio
-11.27